Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy - Test2 - elhamkhani - TriplyDB

Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy

Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy

http://www.wikidata.org/entity/Q35019131

about

Recent advances in treating Parkinson's disease.Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies.Tyrosine kinase inhibition reverses TDP-43 effects on synaptic protein expression, astrocytic function and amino acid dis-homeostasis.Nilotinib - Differentiating the Hope from the Hype.Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.An enhanced recombinant amino-terminal acetylation system and novel in vivo high-throughput screen for molecules affecting α-synuclein oligomerisation.Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches

P2860

Q34554401-5CA8AF41-C8DD-47D4-ADA9-4F44E56DF38E Q37137895-801860D6-35EA-4BA0-9029-2C3AC1BEDEEF Q37225128-186AA507-88CB-474A-99F9-3B62372A4D73 Q38752798-7A604B64-43EC-45E5-9775-67B6A08153CE Q38840128-A7D3672B-84BA-405D-B1C1-F168822B5F67 Q41634845-11AB0C19-23CD-4942-B111-F2D43477DC84 Q42291075-921E08A0-5164-4312-BC95-A75E7024463C Q47860695-FFACDDB8-917A-401C-B092-A22ECDBBA9D5 Q58737028-7BF5E6BE-CED9-4A49-AA6F-0AC50E692CAB

P2860

Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy

http://www.wikidata.org/entity/Q35019131

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Tyrosine Kinase Inhibition Reg ...... Response in α-Synucleinopathy

@ast

Tyrosine Kinase Inhibition Reg ...... Response in α-Synucleinopathy

@en

type

label

Tyrosine Kinase Inhibition Reg ...... Response in α-Synucleinopathy

@ast

Tyrosine Kinase Inhibition Reg ...... Response in α-Synucleinopathy

@en

prefLabel

Tyrosine Kinase Inhibition Reg ...... Response in α-Synucleinopathy

@ast

Tyrosine Kinase Inhibition Reg ...... Response in α-Synucleinopathy

@en

P1433

Q35019131-45B1C23B-A5EB-4B88-A750-0F7064314052

P1476

Q35019131-897B9347-2901-4491-9FB5-53412928AEC7

P2093

Q35019131-043919CC-ACC6-42EA-981B-304641F8E94E

Q35019131-5CECA692-1D83-4EE8-9AB7-D50A8245D42D

Q35019131-86870485-3BEE-4A9E-AE5A-2572A9095E2E

Q35019131-87E665A2-E3AE-4780-ADD4-8274DEA0ED9A

Q35019131-9CE2C7AA-7F59-4A68-A712-7FB11DC1345D

Q35019131-A9142325-184C-4B64-ADBE-133613EC59FD

P2860

Q35019131-00673A6B-F7F4-4C79-925A-0E02D4D9220D

Q35019131-07D4FA93-C49A-4C0A-BB4C-029EB925665D

Q35019131-11BE54CD-A2C6-405D-8CC0-B1089A888943

Q35019131-11F1C80D-A395-43D9-A5CD-4F22B9095FB8

Q35019131-142F36C5-E7C2-4A46-856D-2DC02D963607

Q35019131-154EFE93-7F42-4FE6-A527-1DED91C62743

Q35019131-16F1E79F-9A92-465D-99FB-3FCB9DB7787B

Q35019131-1D654180-4EC0-4D94-9027-D48882899805

Q35019131-2368CBED-DB7B-47F3-873C-2A6AB0E257A7

Q35019131-28944D6F-C2DE-4AFE-A757-4426F283E072

P304

Q35019131-40D8696F-9FC0-47A9-A00A-040DF7FD6DF5

P31

Q35019131-7B537CED-5FD0-4E11-BBA7-592CCD6E3EA1

P356

Q35019131-62918F4D-CF49-44E7-851A-5F6F4BD5C9A0

P478

Q35019131-AA2E2786-02A0-4C13-81E9-22340F596E64

P577

Q35019131-67001263-FE7D-4061-86BE-0B41A5EC9A96

P5875

Q35019131-07792CF7-CF6E-4F5B-A8F5-3E8F6797CB1D

P698

Q35019131-C07D6B3A-F220-4BBC-91B3-C91EDED4C1DB

P932

Q35019131-97F7819B-224B-4509-B2F6-B3992FD33E95

P356

2155-9899.1000259

P1433

Journal of clinical & cellular immunology

P1476

Tyrosine Kinase Inhibition Reg ...... Response in α-Synucleinopathy

@en

P2093

Charbel E-H Moussa

http://www.w3.org/2001/XMLSchema#string

Fernando Pagan

http://www.w3.org/2001/XMLSchema#string

Irina Lonskaya

http://www.w3.org/2001/XMLSchema#string

Michaeline L Hebron

http://www.w3.org/2001/XMLSchema#string

Paul Olopade

http://www.w3.org/2001/XMLSchema#string

Sandra T Selby

http://www.w3.org/2001/XMLSchema#string

P2860

Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus

RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes

Fractalkine-mediated endothelial cell injury by NK cells

Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease

Isolation of interleukin 2-induced immediate-early genes

Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers

P304

259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4172/2155-9899.1000259

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271592124

http://www.w3.org/2001/XMLSchema#string

P698

25635231

http://www.w3.org/2001/XMLSchema#string

P932

4308054

http://www.w3.org/2001/XMLSchema#string